Accessibility Menu
Henry Schein logo

Henry Schein(NASDAQ) HSIC

Market Cap$10.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)+1,914%
5 Year+15%
1 Year+33%
1 Month+0%
Premium Feature
Moneyball Superscore
66/100
$89.78
-1.19%
-1.08Today
After hours$89.83+$0.04 (+0.05%)
Henry Schein last closing stock price
MetricPriceDate
Last closeUSD 89.812026-09-04
Henry Schein stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.32%USD 89.522026-08-28
1 month+0.25%USD 89.592026-08-05
3 month+15.96%USD 77.452026-06-05
Year to date+18.83%USD 75.582025-12-31
1 year+32.5%USD 67.782025-09-04
3 year+20.07%USD 74.802023-09-05
5 year+14.58%USD 78.382021-09-03
Since inception+1,914.35%USD 4.461995-11-03

Henry Schein Financials at a Glance

Market Cap

$10.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$13.60B

Net Income (TTM)

$403.00M

EPS (TTM)

$3.43

P/E Ratio

26.17

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$89.78

Volume

887,873.742

Open

$89.91

Previous Close

$89.81

Daily Range

$89.65 - $90.54

52-Week Range

$61.95 - $92.18

Estimated Earnings Date

Nov 3, 2026

HSIC News

BuyAlert-Green.png

One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan

Jonathan PoncianoDec 29, 2025
GettyImages-1448734270.jpg

Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too?

Josh Kohn-LindquistNov 10, 2025
Foolcom-Featured.png

Henry Schein (HSIC) Q2 EPS Drops 11%

Motley Fool Markets TeamAug 5, 2025
sitting at dental chair dentist patient

3 Dental Supply Stocks You Can Sink Your Teeth Into

James HalleyOct 25, 2023
A couple meeting with an advisor.

3 Market-Beating Stocks That Are Still Great Buys Today

David Jagielski, CPAApr 27, 2022
Getty-stock-market-success

Why Henry Schein, Dean Foods, and SolarEdge Jumped Today

Steve SymingtonMay 7, 2019
GT tire workers

Why Goodyear Tire & Rubber, Henry Schein, and Seattle Genetics Slumped Today

Dan CaplingerFeb 8, 2019
Kitten and puppy holding a stethoscope

Why Henry Schein Stock Dropped 27% Today (But Not Really)

Rich SmithFeb 8, 2019
Page 1

HSIC: Motley Fool Moneyball Superscore

66

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Henry Schein

Henry Schein, Inc. helps dentists and doctors get supplies for their offices. It provides tools like dental chairs and medicine to 1 million customers. It also makes software that helps doctors run their businesses.

What’s on the Menu?

  • Global Dental: Supplies consumable merchandise such as infection control items and dental chairs; accounts for 53.6% of net sales in the three months ended June 27, 2026.
  • Global Medical: Distributes medicine, vaccines, and surgical tools to physician practices and clinics; represented 30.6% of net sales in the three months ended June 27, 2026.
  • Global Specialty Products: Manufactures dental implants and orthodontic supplies; contributed 12.1% of net sales in the three months ended June 27, 2026.
  • Global Technology: Provides practice management software and digital services to help offices stay organized; accounted for 5.2% of net sales in the three months ended June 27, 2026.

Moves to Expand the Reach

  • Committed to a restructuring plan on Aug. 6, 2024, to integrate acquisitions and increase efficiencies.
  • Entered a strategic partnership agreement with KKR in January 2025.
  • Appointed Frederick M. Lowery as the new chief executive officer effective March 2, 2026.
  • Executed a $250 million accelerated share repurchase program in May 2025.

A Global Support Network

The company operates a global network with locations in 34 countries and territories to reach 1 million customers. Its One Schein initiative combines supply chain services, equipment sales, and software into a single program for medical practices.

Performance by the Numbers

  • Net sales were $3.5 billion in the three months ended June 27, 2026, up 6.7% year over year.
  • Gross profit reached $1.1 billion for the three-month period ended June 27, 2026, up 8.3% year over year.
  • Global Technology sales rose 8.2% to $181 million during the three months ended June 27, 2026.
  • Net cash provided by operating activities was $145 million for the six months ended June 27, 2026.

The Evolution of the Business

Henry Schein has transitioned from a traditional distributor to a comprehensive solutions provider for healthcare professionals. This evolution includes expanding into high-margin specialty manufacturing and digital practice management tools.

AI Generated • Aug 5, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

25,000

CEO

Frederick M. Lowery

Website

www.henryschein.com

Headquarters

Melville, NY 11747, US

HSIC Financials

Key Financial Metrics (TTM)

Gross Margin

30.31%

Operating Margin

5.69%

Net Income Margin

2.96%

Return on Equity

12.37%

Return on Capital

10.93%

Return on Assets

3.54%

Earnings Yield

3.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

111.45M

Volume

887.87K

Avg. Volume

1.25M

Financials (TTM)

Gross Profit

$4.12B

Operating Income

$774.00M

EBITDA

$1.03B

Operating Cash Flow

$700.00M

Capital Expenditure

-$161.00M

Free Cash Flow

$539.00M

Cash & ST Invst.

$157.00M

Total Debt

$3.81B

Henry Schein Performance Analysis

Henry Schein annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 12,647,000,0002.0%
20232023-12-31USD 12,339,000,000-2.4%
20242024-12-31USD 12,673,000,0002.7%
20252025-12-31USD 13,184,000,0004.0%
Henry Schein sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-273.1%
Q42025-12-272.9%
Q12026-03-28-2.0%
Q22026-06-272.7%
Henry Schein annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 3.91-11.3%
20232023-12-31USD 3.16-19.2%
20242024-12-31USD 3.05-3.3%
20252025-12-31USD 3.277.1%
Henry Schein sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-2720.0%
Q42025-12-271.2%
Q12026-03-288.2%
Q22026-06-27-10.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.46B

+6.7%

Gross Profit

$1.10B

+15.7%

Gross Margin

31.84%

N/A

Market Cap

$10.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$400.36K

N/A

Employees

25,000

N/A

Net Income

$94.00M

+9.3%

EBITDA

$264.00M

+12.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$157.00M

+8.3%

Total Debt

$3.81B

+13.5%

Accounts Receivable

$1.76B

+7.2%

Inventory

$2.06B

+7.9%

Long Term Debt

$2.58B

+9.6%

Short Term Debt

$1.24B

+22.7%

Return on Assets

3.54%

N/A

Return on Invested Capital

9.81%

N/A

Free Cash Flow

$196.00M

+122.7%

Operating Cash Flow

$242.00M

+101.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AVTRAvantor, Inc.
$14.97-1.45%
BIOBio-Rad Laboratories, Inc.
$386.11-0.46%
MOHMolina Healthcare, Inc.
$200.80-1.04%
GMEDGlobus Medical, Inc.
$78.29+0.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About HSIC

What is the current price of Henry Schein?

Henry Schein is trading at $89.81 per share.

What is the 52-week range for Henry Schein?

Over the past 52 weeks, Henry Schein has traded between $61.95 and $92.18.

How much debt does Henry Schein have?

As of the most recent reporting period, Henry Schein reported total debt of $3.81B.

How much cash does Henry Schein have on hand?

Henry Schein reported $157.00M in cash and cash equivalents in its most recent financial results.

What is Henry Schein’s dividend yield?

Henry Schein does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services